StockData
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc. (BBOT) stock

BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.80−0.14 (-6.96%)

Close on Nov 18, 2026Market cap $144.72MP/E –Yield –

BridgeBio Oncology Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

BridgeBio Oncology Therapeutics's price to book ratio was 0.6× on Nov 11, 2026, against 2.2× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.6×−1.6
2025Dec 31, 20252.2×–

More BridgeBio Oncology Therapeutics figures

See a number that looks wrong?